SEGALL BRYANT & HAMILL, LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.

Quarter-by-quarter ownership
SEGALL BRYANT & HAMILL, LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$14,558,748
-3.9%
142,929
-4.8%
0.17%
+5.7%
Q2 2023$15,157,288
+107490.1%
150,206
-1.9%
0.16%
+4.6%
Q1 2023$14,088
-1.8%
153,138
-3.2%
0.15%
-5.0%
Q4 2022$14,344
-99.9%
158,119
-10.9%
0.16%
-0.6%
Q3 2022$13,498,000
-11.4%
177,453
-1.7%
0.16%
-5.8%
Q2 2022$15,230,000
-6.4%
180,548
-2.5%
0.17%
+9.6%
Q1 2022$16,264,000
-56.3%
185,243
-59.4%
0.16%
-12.8%
Q3 2021$37,198,000
+54.0%
455,744
+72.2%
0.18%
-23.5%
Q2 2021$24,155,000
-2.8%
264,681
-8.9%
0.23%
-4.9%
Q1 2021$24,839,000
-29.2%
290,467
-21.9%
0.25%
-36.9%
Q4 2020$35,097,000
-29.5%
372,004
-35.1%
0.39%
-42.3%
Q3 2020$49,803,000
+3.3%
573,027
+3.7%
0.68%
-16.5%
Q2 2020$48,232,000
+11.0%
552,488
+4.7%
0.81%
-8.2%
Q1 2020$43,442,000
-12.0%
527,892
+1.2%
0.88%
+15.1%
Q4 2019$49,365,000
+8.9%
521,591
-0.1%
0.77%
+8.8%
Q3 2019$45,331,000
-0.7%
521,938
+4.5%
0.70%
+2.0%
Q2 2019$45,655,000
+0.9%
499,656
+6.2%
0.69%
-1.8%
Q1 2019$45,257,000
+37.5%
470,687
+22.7%
0.70%
+24.0%
Q4 2018$32,922,000
+440.7%
383,663
+442.9%
0.57%
+530.0%
Q3 2018$6,089,000
+10.4%
70,674
-3.2%
0.09%
+7.1%
Q2 2018$5,513,000
+44.3%
72,984
+54.5%
0.08%
-4.5%
Q1 2018$3,820,000
-9.0%
47,243
-5.5%
0.09%
-4.3%
Q4 2017$4,196,000
-2.2%
49,975
+0.0%
0.09%
-8.0%
Q3 2017$4,290,000
+4.7%
49,972
+1.8%
0.10%
+3.1%
Q2 2017$4,097,000
+11.5%
49,084
-0.8%
0.10%
+9.0%
Q1 2017$3,675,000
+1.5%
49,478
-0.5%
0.09%
-2.2%
Q4 2016$3,622,000
-5.3%
49,720
+2.7%
0.09%
-7.1%
Q3 2016$3,824,000
+2.6%
48,427
+7.2%
0.10%0.0%
Q2 2016$3,728,000
+9.9%
45,177
-3.5%
0.10%
+16.7%
Q1 2016$3,393,000
-13.4%
46,838
+2.9%
0.08%
-10.6%
Q4 2015$3,917,000
-6.6%
45,524
-0.2%
0.09%
-7.8%
Q3 2015$4,194,000
+195.4%
45,624
+216.0%
0.10%
+218.8%
Q2 2015$1,420,000
-19.8%
14,437
-19.6%
0.03%
-20.0%
Q1 2015$1,770,000
+6.4%
17,9470.0%0.04%
+5.3%
Q4 2014$1,663,000
-1.5%
17,9470.0%0.04%
-2.6%
Q3 2014$1,689,000
+3.9%
17,947
-0.1%
0.04%0.0%
Q2 2014$1,626,000
-51.0%
17,956
-54.0%
0.04%
-2.5%
Q1 2014$3,320,000
-23.0%
39,054
-27.2%
0.04%
-21.6%
Q4 2013$4,310,000
+103.8%
53,620
+94.4%
0.05%
-1.9%
Q3 2013$2,115,000
+7.3%
27,577
-1.1%
0.05%0.0%
Q2 2013$1,972,000
-4.2%
27,892
-3.4%
0.05%
-5.5%
Q1 2013$2,058,00028,8880.06%
Other shareholders
NOVARTIS A G shareholders Q4 2020
NameSharesValueWeighting ↓
NEXTHERA CAPITAL LP 198,000$14,422,0008.45%
PRENTISS SMITH & CO INC 133,202$9,702,0005.92%
EXENCIAL WEALTH ADVISORS, LLC 178,313$12,988,0005.50%
MANAGED ASSET PORTFOLIOS, LLC 185,868$13,538,0005.33%
Osher Van de Voorde Investment Management 114,735$8,357,0004.59%
BROWN BROTHERS HARRIMAN & CO 10,971,272$799,147,0004.37%
PROFESSIONAL ADVISORY SERVICES INC 238,542$17,375,0004.04%
Elefante Mark B 4,579$333,0004.02%
COMPASS CAPITAL MANAGEMENT, INC 271,536$19,779,0003.69%
CGOV Asset Management 972,731$95,135,0003.51%
View complete list of NOVARTIS A G shareholders